QQ客服 官方微博 反馈留言

	DHA increases the anti-tumor effect of gefitinib on non-small cell lung cancer with EGFR mutations in vitro
	Ren, Wangang; Wu, Jing; Wang, Xiaohang; Feng, Zhen; Shang, Xingchen; Peng, Zhongmin
刊名	INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE
	2017
卷号	10期号:5页码:7647-7657
关键词	DHA gefitinib non-small cell lung cancer EGFR mutation
URL标识	查看原文
公开日期	[db:dc_date_available]
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4586535
专题	山东大学
作者单位	Shandong Univ, Shandong Prov Hosp, Dept Thorac Surg, 9677 Jing 10 Rd, Jinan 250000, Shandon
推荐引用方式 GB/T 7714	Ren, Wangang,Wu, Jing,Wang, Xiaohang,et al. DHA increases the anti-tumor effect of gefitinib on non-small cell lung cancer with EGFR mutations in vitro[J]. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE,2017,10(5):7647-7657.
APA	Ren, Wangang,Wu, Jing,Wang, Xiaohang,Feng, Zhen,Shang, Xingchen,&Peng, Zhongmin.(2017).DHA increases the anti-tumor effect of gefitinib on non-small cell lung cancer with EGFR mutations in vitro.INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE,10(5),7647-7657.
MLA	Ren, Wangang,et al."DHA increases the anti-tumor effect of gefitinib on non-small cell lung cancer with EGFR mutations in vitro".INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE 10.5(2017):7647-7657.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。